Early Targeting of Chronic Inflammation That Precedes and Causes Synaptic Loss

On this episode of Pharma's Almanac TV, our Scientific Editor in Chief, David Alvaro, talks to INmune Bio's President and CEO Raymond J. Tesi about the company's unique and revolutionary treatment of chronic inflammation that causes Alzheimer's.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: